Wilson Therapeutics AB
Records under this name other than the patents Wilson Therapeutics AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 6 of 6 · Back to Wilson Therapeutics AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,851,505 | Thiotungstate Analogues and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,233,088 | Bis-Choline Tetrathiomolybdate for Treating Wilson Disease Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,739,051 | Crystalline Particles of Bis-Choline Tetrathiomolybdate Formerly held In force · High confidence | In force | High confidence | |
| US 7,189,865 | Thiomolybdate Analogues and Uses Thereof Formerly held Term ended Term ended Feb 2, 2023 · High confidence | Term ended | Term ended Feb 2, 2023 | High confidence |
| US 6,703,050 | Methods and compositions for the prevention or treatment of cancer Formerly held Term ended Term ended Sep 3, 2019 · USPTO record | Term ended | Term ended Sep 3, 2019 | USPTO record |
| US 7,438,931 | Methods and Compositions for the Treatment of Angiogenic Diseases Formerly held Term ended Ended no later than Sep 3, 2019 · Low confidence | Term ended | Ended no later than Sep 3, 2019 | Low confidence |